keyword
https://read.qxmd.com/read/38590254/cannabidiol-improves-the-cognitive-function-of-samp8-ad-model-mice-involving-the-microbiota-gut-brain-axis
#21
JOURNAL ARTICLE
Bing-Qian Ma, Jian-Xin Jia, He Wang, Si-Jia Li, Zhan-Jun Yang, Xin-Xin Wang, Xu-Sheng Yan
Cannabidiol (CBD), a natural component extracted from Cannabis sativa L . exerts neuroprotective, antioxidant, and anti-inflammatory effects in Alzheimer's disease (AD), a disease characterized by impaired cognition and accumulation of amyloid-B peptides (Aβ). Interactions between the gut and central nervous system (microbiota-gut-brain axis) play a critical role in the pathogenesis of neurodegenerative disorder AD. At present investigations into the mechanisms underlying the neuroprotective action of CBD in AD are not conclusive...
April 9, 2024: Journal of Toxicology and Environmental Health. Part A
https://read.qxmd.com/read/38588401/decrypting-the-multifaceted-peripheral-neuropathy-based-on-molecular-pathology-and-therapeutics-a-comprehensive-review
#22
REVIEW
Praysha Patel, Krishna Thakkar, Div Shah, Umang Shah, Nilesh Pandey, Jayesh Patel, Alkeshkumar Patel
CONTEXT: Peripheral neuropathy (PN) is a multifaceted complication characterized by nerve damage due to oxidative stress, inflammatory mediators, and dysregulated metabolic processes. Early PN manifests as sensory changes that develop progressively in a "stocking and glove" pattern. METHODS AND MECHANISMS: A thorough review of literature has been done to find the molecular pathology, clinical trials that have been conducted to screen the effects of different drugs, current treatments and novel approaches used in PN therapy...
April 8, 2024: Archives of Physiology and Biochemistry
https://read.qxmd.com/read/38588037/impact-of-cannabidiol-on-brain-glucose-metabolism-of-c57bl-6-male-mice-previously-exposed-to-cocaine
#23
JOURNAL ARTICLE
Lidia Emmanuela Wiazowski Spelta, Caroline Cristiano Real, Vitor Bruno, Carlos Alberto Buchpiguel, Raphael Caio Tamborelli Garcia, Larissa Helena Torres, Daniele de Paula Faria, Tania Marcourakis
Despite evidence of the beneficial effects of cannabidiol (CBD) in animal models of cocaine use disorder (CUD), CBD neuronal mechanisms remain poorly understood. This study investigated the effects of CBD treatment on brain glucose metabolism, in a CUD animal model, using [18 F]FDG positron emission tomography (PET). Male C57Bl/6 mice were injected with cocaine (20 mg/kg, i.p.) every other day for 9 days, followed by 8 days of CBD administration (30 mg/kg, i.p.). After 48 h, animals were challenged with cocaine...
April 2024: Journal of Neuroscience Research
https://read.qxmd.com/read/38587319/a-novel-insight-into-the-neuroprotective-effects-of-cannabidiol-maintained-apelin-dopamine-synthesis-nrf2-signaling-and-akt-creb-bdnf-gene-expressions
#24
JOURNAL ARTICLE
Melike Doğan Ünlü, Sanem Aşçı, Orhan İmeci, Adem Milletsever, Özlem Özmen, Serdar Sezer, Serpil Demirci
Neuroinflammation is a process associated with degeneration and loss of neurons in different parts of the brain. The most important damage mechanisms in its formation are oxidative stress and inflammation. This study aimed to investigate the protective effects of cannabidiol (CBD) against neuroinflammation through various mechanisms. Thirty‑two female rats were randomly divided into 4 groups as control, lipopolysaccharide (LPS), LPS + CBD and CBD groups. After six hours following LPS administration, rats were sacrificed, brain and cerebellum tissues were obtained...
March 28, 2024: Acta Neurobiologiae Experimentalis
https://read.qxmd.com/read/38586491/les-donn%C3%A3-es-probantes-et-les-recommandations-sur-le-cannabis-%C3%A3-des-fins-m%C3%A3-dicales-chez-les-enfants
#25
REVIEW
Lauren E Kelly, Michael J Rieder, Yaron Finkelstein
L'intérêt envers l'utilisation des produits du cannabis à des fins médicales chez les enfants de moins de 18 ans augmente. De nombreux produits du cannabis à des fins médicales contiennent du cannabidiol, du delta-9-tétrahydrocannabinol ou ces deux produits. Malgré les nombreuses prétentions thérapeutiques, peu d'études rigoureuses guident la posologie, l'innocuité et l'efficacité du cannabis à des fins médicales en pédiatrie clinique...
May 2024: Paediatrics & Child Health
https://read.qxmd.com/read/38586483/medical-cannabis-for-children-evidence-and-recommendations
#26
REVIEW
Lauren E Kelly, Michael J Rieder, Yaron Finkelstein
Interest in using cannabis products for a medical purpose in children under the age of 18 years is increasing. There are many medical cannabis products available that can include cannabidiol (CBD) or delta-9-tetrahydrocannabinol (THC), or both. Despite many therapeutic claims, there are few rigorous studies to inform the dosing, safety, and efficacy of medical cannabis in paediatric clinical practice. This statement reviews the current evidence and provides recommendations for using medical cannabis in children...
May 2024: Paediatrics & Child Health
https://read.qxmd.com/read/38585296/pharmacokinetic-of-two-oral-doses-of-a-1-20-thc-cbd-cannabis-herbal-extract-in-cats
#27
JOURNAL ARTICLE
Chloe Lyons, Katelyn McEwan, Meara Munn-Patterson, Stephanie Vuong, Jane Alcorn, Alan Chicoine
OBJECTIVE: To determine the pharmacokinetics (PK) of two oral doses of a Cannabis herbal extract (CHE) containing 1:20 THC:CBD in 12 healthy Domestic Shorthair cats. METHODS: Single-dose PK were assessed after oral administration of CHE at low or high dose (2 mg CBD + 0.1 mg THC, or 5 mg CBD + 0.25 mg THC per kg bw, respectively; n  = 6 per group) in fasting cats. Blood samples were drawn up to 48 h following CHE administration...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38584388/cannabidiol-for-behavior-symptoms-in-alzheimer-s-disease-canbis-ad-a-randomized-double-blind-placebo-controlled-trial
#28
JOURNAL ARTICLE
Latha Velayudhan, Marta Dugonjic, Sara Pisani, Lucy Harborow, Dag Aarsland, Paul Bassett, Sagnik Bhattacharyya
No abstract text is available yet for this article.
April 8, 2024: International Psychogeriatrics
https://read.qxmd.com/read/38583854/cannabidiol-induces-erk-activation-and-ros-production-to-promote-autophagy-and-ferroptosis-in-glioblastoma-cells
#29
JOURNAL ARTICLE
Na Young Kim, Siddegowda Gopalapura Shivanne Gowda, Seok-Geun Lee, Gautam Sethi, Kwang Seok Ahn
Small molecule-driven ERK activation is known to induce autophagy and ferroptosis in cancer cells. Herein the effect of cannabidiol (CBD), a phytochemical derived from Cannabis sativa, on ERK-driven autophagy and ferroptosis has been demonstrated in glioblastoma (GBM) cells (U87 and U373 cells). CBD imparted significant cytotoxicity in GBM cells, induced activation of ERK (not JNK and p38), and increased intracellular reactive oxygen species (ROS) levels. It increased the autophagy-related proteins such as LC3 II, Atg7, and Beclin-1 and modulated the expression of ferroptosis-related proteins such as glutathione peroxidase 4 (GPX4), SLC7A11, and TFRC...
April 5, 2024: Chemico-biological Interactions
https://read.qxmd.com/read/38583687/cannabidiol-and-positive-effects-on-object-recognition-memory-in-an-in-vivo-model-of-fragile-x-syndrome-obligatory-role-of-hippocampal-gpr55-receptors
#30
JOURNAL ARTICLE
Antonia Manduca, Valeria Buzzelli, Alessandro Rava, Alessandro Feo, Emilia Carbone, Sara Schiavi, Barbara Peruzzi, Valentina D'Oria, Marco Pezzullo, Andrea Pasquadibisceglie, Fabio Polticelli, Vincenzo Micale, Martin Kuchar, Viviana Trezza
Cannabidiol (CBD), a non-psychotomimetic constituent of Cannabis sativa, has been recently approved for epileptic syndromes often associated with Autism spectrum disorder (ASD). However, the putative efficacy and mechanism of action of CBD in patients suffering from ASD and related comorbidities remain debated, especially because of the complex pharmacology of CBD. We used pharmacological, immunohistochemical and biochemical approaches to investigate the effects and mechanisms of action of CBD in the recently validated Fmr1-Δ exon 8 rat model of ASD, that is also a model of Fragile X Syndrome (FXS), the leading monogenic cause of autism...
April 5, 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38574834/decoding-epilepsy-treatment-a-comparative-evaluation-contrasting-cannabidiol-pharmacokinetics-in-adult-and-paediatric-populations
#31
REVIEW
Mohamed Osman, Jamileh Khalil, Mostafa El-Bahri, Jamal Swalah Mcdahrou, Reem Fahda, Reymin Mustafa, Arthur Ooi, Marwa Attayee, Rachelle Catanzariti, Lisa Pont, Kylie Williams, Stewart Yeung, Kamal Dua, Gabriele De Rubis, Raimar Loebenberg
Epilepsy is a neurological disorder characterized by overstimulation of neurotransmitters and uncontrolled seizures. Current medications for epilepsy result in adverse effects or insufficient seizure control, highlighting the necessity to develop alternative therapies. Cannabidiol (CBD), derived from cannabis plants, has been popularly explored as an alternative. CBD is shown to have anti-convulsivatng and muscle-relaxing properties, which have been used in patients with epilepsy with promising results. Current research explores varying dosages in either adult or paediatric patients, with little or no comparison between the two populations...
April 3, 2024: Chemico-biological Interactions
https://read.qxmd.com/read/38574212/diabetic-peripheral-neuropathy-prevention-and-treatment
#32
JOURNAL ARTICLE
Scott Bragg, Sarah Tucker Marrison, Sean Haley
Diabetic peripheral neuropathy occurs in up to 50% of patients with diabetes mellitus and increases the risk of diabetic foot ulcers and infections. Consistent screening and clear communication are essential to decrease disparities in assessment of neuropathic symptoms and diagnosis. Physicians should address underlying risk factors such as poor glycemic control, vitamin B12 deficiency, elevated blood pressure, and obesity to reduce the likelihood of developing neuropathy. First-line drug therapy for painful diabetic peripheral neuropathy includes duloxetine, gabapentin, amitriptyline, and pregabalin; however, these medications do not restore sensation to affected extremities...
March 2024: American Family Physician
https://read.qxmd.com/read/38572913/correction-to-efficacy-of-cannabidiol-in-convulsive-and-nonconvulsive-seizure-types-associated-with-treatment-resistant-epilepsies-in-the-expanded-access-program
#33
(no author information available yet)
No abstract text is available yet for this article.
April 4, 2024: Epilepsia
https://read.qxmd.com/read/38572744/influence-of-short-term-chronic-oral-cannabidiol-application-on-muscle-recovery-and-performance-after-an-intensive-training-protocol-a-randomized-double-blind-crossover-study
#34
JOURNAL ARTICLE
Eduard Isenmann, Sebastian Veit, Ulrich Flenker, Alessio Lesch, Dirk W Lachenmeier, Patrick Diel
BACKGROUND: Rapid regeneration after intense exercise is essential for competitive athletes. Based on this assumption, supplementation strategies, focusing on food supplements, are increasing to improve the recovery processes. One such supplement is cannabidiol (CBD) which is gaining more attention in competitive sports. However, the evidence is still lacking and there are no data available about the effect of a short-term chronic application. METHODS: A three-arm double-blind cross-over study was conducted to determine the effects of two different CBD products on performance, muscle damage and inflammatory processes in well-trained athletes...
December 2024: Journal of the International Society of Sports Nutrition
https://read.qxmd.com/read/38570005/uncovering-the-metabolite-complexity-and-variability-of-cultivated-hemp-cannabis-sativa-l-a-first-phytochemical-diversity-mapping-in-greece
#35
JOURNAL ARTICLE
Petros S Tzimas, Stavros Beteinakis, Eleftherios A Petrakis, Panayiota T Papastylianou, Ioanna Kakabouki, Andrea L Small-Howard, Leandros A Skaltsounis, Maria Halabalaki
The high value of fiber-type Cannabis sativa L. (hemp) due to its phytochemicals has yet to be fully recognized and leveraged. Besides cannabidiol (CBD), which is the most prevalent non-psychoactive cannabinoid, hemp contains numerous other cannabinoids with unexplored bioactivities, in addition to various compound classes. Previous works have aimed to correlate chemical profiles of C. sativa inflorescences with important parameters, mostly based on experiments under controlled conditions. However, mapping studies that explore the phytochemical diversity of hemp in a more realistic context are crucial to guide decisions at multiple levels, especially in areas where hemp cultivation was recently re-authorized, including Mediterranean countries...
April 1, 2024: Phytochemistry
https://read.qxmd.com/read/38569457/low-uv-radiation-influenced-dna-methylation-gene-regulation-cell-proliferation-viability-and-biochemical-differentiation-in-the-cell-suspension-cultures-of-cannabis-indica
#36
JOURNAL ARTICLE
Maryam Abedini, Alireza Iranbakhsh, Sara Saadatmand, Mostafa Ebadi, Zahra Oraghi Ardebili
The effect of low artificial Ultraviolet (UV) on the DNA methylation remains controversial. This study addresses how differential photoperiods of UV radiation affect the biochemical and molecular behaviors of Cannabis indica cell suspension cultures. The cell suspensions were illuminated with the compact fluorescent lamps (CFL), emitting a combination of 10% UVB, 30% UVA, and the rest visible wavelengths for 0, 4, 8, and 16 h. The applied photoperiods influenced cell morphological characteristics. The 4 h photoperiod was the most effective treatment for improving biomass, growth index and cell viability percentage while these indices remained non-significant in the 16 h treatment...
March 29, 2024: Journal of Photochemistry and Photobiology. B, Biology
https://read.qxmd.com/read/38568425/antimicrobial-and-antibiofilm-effect-of-cannabinoids-from-cannabis-sativa-against-methicillin-resistant-staphylococcus-aureus-mrsa-causing-bovine-mastitis
#37
JOURNAL ARTICLE
Mayank Roshan, Ila Singh, Ashutosh Vats, Manisha Behera, Dravin Pratap Singh, Devika Gautam, Shiveeli Rajput, Jitesh Tarak, Gopinath Packirisamy, Sachinandan De
Antimicrobial resistance (AMR) poses a serious threat to human, animal, and plant health on a global scale. Search and elimination techniques should be used to effectively counter the spread of methicillin-resistant Staphylococcus aureus (MRSA) infections. With only a few novel drugs in clinical development, the quest for plant-based alternatives to prevent the spread of antibiotic resistance among bacteria has accelerated. Treatment of MRSA infections is challenging owing to rapidly emerging resistance mechanisms coupled with their protective biofilms...
April 3, 2024: International Microbiology: the Official Journal of the Spanish Society for Microbiology
https://read.qxmd.com/read/38562466/product-labeling-accuracy-and-contamination-analysis-of-commercially-available-cannabidiol-product-samples
#38
JOURNAL ARTICLE
Barry E Gidal, Ryan Vandrey, Chela Wallin, Sean Callan, Alan Sutton, Timothy B Saurer, Jennifer L Triemstra
Background and objective: Commercially available cannabidiol (CBD) products are increasingly being used for medicinal purposes, including for the treatment of various neurological conditions, but there are growing concerns around adherence to quality control measures that protect consumers. This study was conducted to assess the purity and label accuracy of commercially available CBD products. Methods: Commercially available CBD products were chosen from the open stream of commerce in the United States based on formulations as a tincture, gummy, vape, or topical product...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38561958/cannabidiol-use-in-france-in-2022-results-from-a-nationwide-representative-sample-of-adults
#39
JOURNAL ARTICLE
Tangui Barré, Emmanuel Lahaie, Vincent Di Beo, Patrizia Carrieri, Raphaël Andler, Viêt Nguyen-Thanh, François Beck
INTRODUCTION: Cannabidiol (CBD) is a non-intoxicating cannabis compound found in diverse commercial products worldwide. However, its use may not be fully harmless. Accordingly, it is important to document the prevalence of CBD use and user characteristics in the general population. METHODS: We conducted a nationwide survey from a random sample of adults living in France using computer-assisted telephone interviews between 2 March and 9 July 2022. We estimated the prevalence of CBD awareness and CBD use, and explored the different routes of administration...
April 1, 2024: Drug and Alcohol Review
https://read.qxmd.com/read/38561178/pharmacodynamic-effects-following-co-administration-of-cannabinoids-and-opioids-a-scoping-review-of-human-experimental-studies
#40
JOURNAL ARTICLE
David Guy, Jared C Wootten, Michael Wong, Daniel Turski, Mark Lukewich, Abdulrahman Alboog, Abirami R Kandasamy, Jonathan Gregory, Raju Poolacherla
BACKGROUND: Cannabinoids are increasingly used in the management of chronic pain. Although analgesic potential has been demonstrated, cannabinoids interact with a range of bodily functions that are also influenced by chronic pain medications, including opioids. OBJECTIVE: We performed a scoping review of literature on the pharmacodynamic effects following co-administration of cannabinoids and opioids. METHODS: We systematically searched EMBASE, PubMed, and PsycINFO for studies that experimentally investigated the co-effects of cannabinoids and opioids in human-subjects...
April 1, 2024: Pain Medicine
keyword
keyword
1686
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.